ESC & iPSC News Volume 10.32 | Aug 26 2015

    0
    74

    ESC & iPSC News 10.32 August 26, 2015

    ESC & iPSC News

         In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
    Cell Therapy News on Facebook  ESC on Twitter

     
    TOP STORY
    Limiting Replication Stress during Somatic Cell Reprogramming Reduces Genomic Instability in Induced Pluripotent Stem Cells
    Researchers showed that, similar to the phenomenon of oncogene-induced replication stress, the expression of reprogramming factors induces replication stress. Increasing the levels of the checkpoint kinase 1 reduced reprogramming-induced replication stress and increased the efficiency of induced pluripotent stem cells generation. [Nat Commun] Full Article
    Free Wallchart from Nature Reviews Neuroscience on Modeling Neurological Disease with iPS Cells

     
    PUBLICATIONS (Ranked by impact factor of the journal)
    PRC2 Is Required to Maintain Expression of the Maternal Gtl2-Rian-Mirg Locus by Preventing De Novo DNA Methylation in Mouse Embryonic Stem Cells
    Scientists showed that polycomb repressive complex 2 (PRC2) is required to maintain expression of maternal microRNAs and long non-coding RNAs from the Gtl2-Rian-Mirg locus, which is essential for full pluripotency of induced pluripotent stem cells. [Cell Rep] Full Article | Graphical Abstract

    Functional Gene Correction for Cystic Fibrosis in Lung Epithelial Cells Generated from Patient iPSCs
    Investigators generated induced pluripotent stem cells (iPSCs) from cystic fibrosis patients carrying a homozygous deletion of F508 in the cystic fibrosis transmembrane regulator gene (CFTR), which resulted in defective processing of CFTR to the cell membrane. [Cell Rep] Full Article | Graphical Abstract

    Ube2s Regulates Sox2 Stability and Mouse ES Cell Maintenance
    Scientists identified ubiquitin-conjugating enzyme E2S (Ube2s) as a novel effector for Sox2 protein degradation. Ube2s mediated K11-linked polyubiquitin chain formation at the Sox2-K123 residue, thus marking it for proteasome-mediated degradation. [Cell Death Differ] Abstract

    Bcl3 Bridges LIF-STAT3 to Oct4 Signaling in the Maintenance of Naïve Pluripotency
    Scientists verified B cell leukemia/lymphoma 3 (Bcl3) as the most significantly downregulated factor following leukemia inhibitory factor (LIF) withdrawal in mouse embryonic stem cells (mESCs). Bcl3 knockdown altered mESC morphology, reduced expression of pluripotency genes including Oct4, Sox2 and Nanog, and downregulated DNA binding of acetylated histone 3 and RNA polymerase II on the Oct4 promoter. [Stem Cells] Abstract

    Heterogeneous Lineage Marker Expression in Naive Embryonic Stem Cells Is Mostly Due to Spontaneous Differentiation
    Researchers showed the transcriptome of Nanog-negative cells exhibited expression of classes of genes associated with differentiation that are not yet active in cells exposed to differentiation conditions for one day. [Sci Rep] Full Article

    Glycosyltransferase ST6GAL1 Contributes to the Regulation of Pluripotency in Human Pluripotent Stem Cells
    Investigators observed that the sialyltransferase ST6GAL1 was preferentially expressed in undifferentiated human pluripotent stem cells compared to non-pluripotent cells. [Sci Rep] Full Article

    Reprogramming Roadblocks Are System Dependent
    Scientists demonstrated that reprogramming triggered by less efficient polycistronic reprogramming cassettes not only highlights mesenchymal-to-epithelial transition (MET) as a roadblock but also faces more severe difficulties to attain a pluripotent state even post-MET. [Stem Cell Rep] Full Article | Graphical Abstract

    Nucleosome Organization in Human Embryonic Stem Cells
    Researchers revealed that the genome is a determinant of nucleosome organization with transcriptionally inactive regions characterized by a “ground state” of nucleosome profiles driven by underlying DNA sequences. [PLoS One] Full Article

    Uniparental Disomy of the Entire X Chromosome in Turner Syndrome Patient-Specific Induced Pluripotent Stem Cells
    Scientists generated induced pluripotent stem cells from four 45,X chorionic villous fibroblast lines and found that only one reprogrammed line acquired 46,XX karyotype via uniparental disomy of the entire X chromosome. [Cell Disc] Full Article

    Request a sample for simple differentiation with STEMdiffâ„¢ Mesoderm Induction Medium

     
    REVIEWS
    Induced Pluripotent Stem Cells: A New Frontier for Stem Cells in Dentistry
    The authors summarize the dental tissues that have successfully been utilized to generate induced pluripotent stem cell (iPSC) lines, as well as the potential uses of iPSCs for tissue regeneration in different dental applications. [J Dent Res] Abstract

    Visit our reviews page to see a complete list of reviews in the ESC & iPSC research field.

    IBC’s Cell Therapy Bioprocessing & Commercialization meeting

     
    INDUSTRY NEWS
    STEMCELL Technologies Inc. Enters a Licensing Agreement with iPS Academia Japan, Inc. for Induced Pluripotent Stem Cell Research Technologies
    STEMCELL Technologies Inc. has signed a patent license agreement with iPS Academia Japan, Inc. to license and commercialize iPS Academia Japan, Inc.’s patented technologies for induced pluripotent stem cell (iPS cell) research. [STEMCELL Technologies Inc. (Business Wire)] Press Release

    $52M NIH Grant Advances Clinical and Translational Research at UC San Diego
    The Clinical and Translational Research Institute at University of California, San Diego has received a five-year Clinical and Translational Science Award for approximately $52 million from the National Center for Advancing Translational Science, part of the National Institutes of Health (NIH). [UC San Diego Health] Press Release

    From our sponsor: Induce neural progenitor cells faster and more effectively. Watch the technical video.

     
    POLICY NEWS
    China Announces Stem-Cell Rules
    Chinese stem-cell scientists have welcomed long-awaited measures that, state media claim, will rein in rogue use of stem cells in clinics while allowing research. [Nature News] Editorial

    Faked Peer Reviews Prompt 64 Retractions
    A leading scientific publisher has retracted 64 articles in ten journals, after an internal investigation discovered fabricated peer-review reports linked to the articles’ publication. Berlin-based Springer announced the retractions in a statement. [Nature News] Editorial

     
    EVENTS
    NEW 3rd Annual Cell Culture & Bioprocessing Asia Congress 2015
    October 15-16, 2015
    Singapore, Singapore

    Visit our events page to see a complete list of events in the ESC & iPSC community.

     
    JOB OPPORTUNITIES
    NEW Postdoctoral Research Fellow – Development and Pathogenesis of Pancreatic Cancer (University College London)

    Scientist – Human Pluripotent Stem Cell Biology (STEMCELL Technologies Inc.)

    Postdoctoral Fellow – (Johns Hopkins University School of Medicine)

    Senior Research Technician – Cancer and Inflammatory Bowel Disease (Qu Biologics)

    Advanced Research Assistant – Gene Targeting (Wellcome Trust Sanger Institute)

    Head of Research – Cellular Operations (Welcome Trust Sanger Institute)

    Postdoctoral Research Fellow – Epigenetics (Institute of Molecular Biology Mainz)

    Postdoctoral Position – Stem Cell Biophysics (University Paris Diderot)

    MICA Stem Cell Scientist (Medicines and Healthcare Products Regulatory Agency)

    Stem Cell Scientist (Medicines and Healthcare Products Regulatory Agency)


    Recruit Top Talent: Reach more than 60,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

     

    Have we missed an important article or publication in ESC & iPSC News? Click here to submit!

    Comments or suggestions? Submit your feedback here

    Learn more about ESC & iPSC News: Archives | Events | Contact Us